NATCO

What NATCO does

NATCO is a privately held pharmaceutical manufacturer and supplier headquartered in Mississauga, Canada. Founded in 2012, the company operates as a for-profit enterprise with a workforce of 11-50 employees and is led by Chief Executive Officer Glenn Ikeda. Its public-facing digital presence is via natcopharma.ca. Detailed information on product portfolio, manufacturing technology, pricing model, go-to-market strategy, customer segments, and revenue mechanics is not present in the available source data, so the precise functional scope of NATCO's pharmaceutical activities (e.g., generic drug manufacturing, specialty distribution, finished-dosage formulation) cannot be specified from the inputs.

The source data also contains corporate action disclosures attributed to "Natco Pharma" with public ticker references (NSE: NATCOPHARM / BSE: 524816), including a board-approved agrochemicals business demerger into a new wholly owned subsidiary, the planned establishment of a wholly owned Nigerian subsidiary, and the liquidation of an Australian subsidiary. These actions reference a publicly listed Indian pharmaceutical entity and may not pertain directly to the Canadian NATCO at natcopharma.ca; however, no clarifying source explicitly disambiguates the two entities, so a possible corporate affiliation or naming overlap cannot be ruled out from the data provided.

Name

NATCO

Website

https://natcopharma.ca

Company type

Public

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

NATCO is a privately held Canadian pharmaceutical manufacturer and supplier headquartered in Mississauga, founded in 2012, with 11-50 employees and led by CEO Glenn Ikeda. Source data also references corporate restructuring linked to Natco Pharma (NSE: NATCOPHARM).

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

OTC & Consumer Health Distributors (HLAIAJAC)

Keywords

• Generic pharmaceuticals
• Drug manufacturing
• Pharmaceutical supply
• Prescription medicines
• Pharmaceutical distribution

Headquarters

HQ city

Mississauga

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel

Core offering

NATCO is a pharmaceutical manufacturer and supplier based in Mississauga, Canada. Founded in 2012, the company produces and distributes pharmaceutical products to business customers, operating with a small team of 11-50 employees in the Canadian pharmaceutical market.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical products Pharmaceutical products manufactured and supplied by NATCO to business customers in the Canadian market, including pharmacies, hospitals, and pharmaceutical distributors.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves6 records

Expansion highlights2 records

Broad incumbents

• Viatris (Canada): Canadian operations of Viatris, the global generics and specialty manufacturer formed by Mylan-Upjohn. Comparable to NATCO as a large incumbent active across generic manufacturing and supply in Canada.
• Aurobindo Pharma (Canada): Canadian distribution and supply operations of Indian generics major Aurobindo Pharma. Comparable to NATCO as a generics supplier active in Canadian retail and institutional channels, with broader global manufacturing capacity.
• Sandoz Canada: Canadian generics and biosimilars business of Sandoz/Novartis. Comparable as a broad incumbent generic manufacturer and supplier competing with NATCO for Canadian distribution and institutional contracts.
• Hikma Pharmaceuticals Canada: Canadian affiliate of Hikma Pharmaceuticals, a multinational generics manufacturer. Overlaps with NATCO in supplying generic pharmaceutical products into Canadian hospital, retail, and institutional channels.
• Teva Canada: Canadian arm of Teva Pharmaceutical Industries, one of the world's largest generic drug manufacturers. Overlaps with NATCO across generic manufacturing and supply into Canadian pharmacy and hospital channels.

Direct peers

• Apotex Inc. Canada's largest generic pharmaceutical manufacturer, headquartered in Toronto. Directly comparable to NATCO as a domestic producer and supplier of generic drug products serving Canadian and international markets.
• Pharmascience Inc. Montreal-based privately held pharmaceutical manufacturer of generic and OTC products. Closely comparable to NATCO as a Canadian private pharma manufacturer operating in similar product categories and channels.
• Jamp Pharma Group: Canadian private generic pharmaceutical manufacturer and distributor. Comparable to NATCO in scale, business model (manufacture plus distribution), and Canadian market focus on generics and OTC products.
• Sterinova Inc. Canadian specialty injectable pharmaceutical manufacturer based in Quebec. Comparable to NATCO as a smaller Canadian pharma manufacturer focused on niche generic and specialty supply rather than broad-line commodity generics.
• Mint Pharmaceuticals: Canadian-based generic pharmaceutical manufacturer and distributor serving Canadian retail and institutional markets. Comparable to NATCO in scale, product scope, and dual manufacturer/distributor business model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NATCO